MAM
McLean Asset Management Portfolio holdings
AUM
$381M
This Quarter Return
-2%
1 Year Return
+12.74%
3 Year Return
+53.81%
5 Year Return
–
10 Year Return
–
AUM
$303M
AUM Growth
+$303M
(-9.1%)
Cap. Flow
+$13.5M
Cap. Flow
% of AUM
4.46%
Top 10 Holdings %
Top 10 Hldgs %
53.68%
Holding
161
New
8
Increased
63
Reduced
68
Closed
12
Top Buys
| 1 |
Apple
AAPL
|
$6.4M |
| 2 |
Dimensional US Core Equity 2 ETF
DFAC
|
$2.33M |
| 3 |
Avantis Emerging Markets Equity ETF
AVEM
|
$1.63M |
| 4 |
Avantis US Equity ETF
AVUS
|
$1.53M |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
$1.33M |
Top Sells
Sector Composition
| 1 | Technology | 10.82% |
| 2 | Financials | 3.83% |
| 3 | Healthcare | 2.39% |
| 4 | Consumer Discretionary | 1.81% |
| 5 | Communication Services | 1.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| $476K | 0.16% |
2,739
+3
| +0.1% | +$521 |
|
77
O'Reilly Automotive
ORLY
$88B
| $472K | 0.16% |
359
+3
| +0.8% | +$3.95K |
|
78
KLA
KLAC
$115B
| $464K | 0.15% |
773
-47
| -6% | -$28.2K |
|
79
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $436K | 0.14% |
10,922
-14,587
| -57% | -$582K |
|
80
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $434K | 0.14% |
+9,503
| New | +$434K |
|
81
Broadcom
AVGO
$1.4T
| $429K | 0.14% |
2,748
-15
| -0.5% | -$2.34K |
|
82
Union Pacific
UNP
$133B
| $427K | 0.14% |
2,051
+24
| +1% | +$5K |
|
83
Philip Morris
PM
$260B
| $427K | 0.14% |
2,862
-258
| -8% | -$38.5K |
|
84
AstraZeneca
AZN
$248B
| $420K | 0.14% |
6,479
+115
| +2% | +$7.46K |
|
85
Procter & Gamble
PG
$368B
| $409K | 0.14% |
2,581
-148
| -5% | -$23.4K |
|
86
Netflix
NFLX
$513B
| $386K | 0.13% |
443
+35
| +9% | +$30.5K |
|
87
Vanguard Intermediate-Term Treasury ETF
VGIT
$32.3B
| $372K | 0.12% |
6,265
-3,107
| -33% | -$184K |
|
88
Goldman Sachs
GS
$226B
| $364K | 0.12% |
788
-56
| -7% | -$25.9K |
|
89
Verizon
VZ
$186B
| $364K | 0.12% |
8,636
-752
| -8% | -$31.7K |
|
90
Cencora
COR
$56.5B
| $362K | 0.12% |
1,316
+13
| +1% | +$3.57K |
|
91
Fair Isaac
FICO
$36.5B
| $354K | 0.12% |
211
+1
| +0.5% | +$1.68K |
|
92
Roper Technologies
ROP
$56.6B
| $353K | 0.12% |
680
+14
| +2% | +$7.27K |
|
93
CVS Health
CVS
$92.8B
| $347K | 0.11% |
+5,127
| New | +$347K |
|
94
Bristol-Myers Squibb
BMY
$96B
| $346K | 0.11% |
6,511
-151
| -2% | -$8.01K |
|
95
Manhattan Associates
MANH
$13B
| $342K | 0.11% |
2,374
-14
| -0.6% | -$2.02K |
|
96
Honeywell
HON
$139B
| $321K | 0.11% |
1,754
-1,721
| -50% | -$315K |
|
97
TJX Companies
TJX
$152B
| $320K | 0.11% |
2,662
+28
| +1% | +$3.36K |
|
98
Northrop Grumman
NOC
$84.5B
| $318K | 0.1% |
646
+10
| +2% | +$4.92K |
|
99
CSX Corp
CSX
$60.6B
| $315K | 0.1% |
11,800
-1,848
| -14% | -$49.3K |
|
100
McKesson
MCK
$85.4B
| $314K | 0.1% |
481
+9
| +2% | +$5.88K |
|